Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.
Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, Chieregato K, Mozzo V, Perbellini O, Tisi MC, Trentin L, Visco C, Ruggeri M, Sommaggio R, Rosato A.
Dalla Pietà A, et al. Among authors: palmerini p.
J Immunother Cancer. 2021 Jul;9(7):e002475. doi: 10.1136/jitc-2021-002475.
J Immunother Cancer. 2021.
PMID: 34272306
Free PMC article.